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Regulatory T (Treg) cells maintain immune homeo-
stasis and prevent inflammatory and autoimmune re-
sponses. During development, thymocytes bearing a
moderately self-reactive T cell receptor (TCR) can be
selected to become Treg cells. Several observations
suggest that also in the periphery mature Treg cells
continuously receive self-reactive TCR signals. How-
ever, the importance of this inherent autoreactivity
for Treg cell biology remains poorly defined. To
address this open question, we genetically ablated
the TCR of mature Treg cells in vivo. These ex-
periments revealed that TCR-induced Treg lineage-
defining Foxp3 expression and gene hypomethyla-
tion were uncoupled from TCR input in mature Treg
cells. However, Treg cell homeostasis, cell-type-spe-
cific gene expression and suppressive function criti-
cally depend on continuous triggering of their TCR.
INTRODUCTION
The generation of a peripheral T cell pool with a broad diversity of
T cell receptors (TCRs) is critical for a functional immune system.
The random nature of somatic TCR gene assembly ensures that
a large number of foreign antigens can be recognized. However,
this process bears the inherent problem that self-reactive TCRs722 Immunity 41, 722–736, November 20, 2014 ª2014 Elsevier Inc.are also generated. Central and peripheral tolerance mecha-
nisms delete autoreactive T cells or render them ineffective
(Xing and Hogquist, 2012). During thymic T cell development,
most T cells with a strong self-reactivity to peptide-major
histocompatibility complex (MHC) complexes are deleted.
Some cells showing intermediate self-reactivity are instructed
to develop into regulatory T (Treg) cells, a process known as
agonist selection (Josefowicz et al., 2012; Xing and Hogquist,
2012). Treg cells suppress the expansion and function of (auto-
reactive) effector T cells and their absence or dysfunction leads
to severe T cell-mediated pathologies in man and mouse (Jose-
fowicz et al., 2012; Sakaguchi et al., 2008). Treg cells act mostly
by suppressing the expansion and function of effector T cells,
through various direct and indirect mechanisms.
The key lineage-defining transcription factor Forkhead Box P3
(Foxp3), together with other transcriptional regulators, controls
the expression of gene programs necessary to induce and main-
tain Treg cell identity and function. Foxp3 regulates gene expres-
sion mostly in conjunction with other transcriptional regulators,
depending on the type of the immune response and the tissue
where this response takes place (Fu et al., 2012; Rudra et al.,
2012; Stephens et al., 2007). In addition, the establishment of a
Treg cell-specific hypomethylation pattern ensures a transcrip-
tionally poised state in a set of Treg cell core genes (Ohkura
et al., 2012).
Importantly, these two lineage-defining characteristics of Treg
cells, namely Foxp3 expression and the specific hypomethylated
state, are induced by rather strong, and in the latter case long-
lasting, TCR signals in developing Treg cells. Interruption of
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leads to reduced splenic, but increased lymph node Foxp3+ Treg
cell numbers. These Lck-deficient Treg cells display deficiencies
in Treg cell signature genes (Kim et al., 2009). Furthermore, amu-
tation in LAT abolishing its ability to bind to PLCg1 severely inter-
feres with Treg cell, but not conventional T cell, development
(Koonpaew et al., 2006).
Peripheral Treg cell identity depends on continued Foxp3
expression, underscoring its critical importance. Furthermore,
the majority of Treg cells express high amounts of CD25, the a
chain of the high-affinity IL-2 receptor, and their survival and
full Foxp3 expression depends on IL-2 (Josefowicz et al.,
2012). The importance of TCR signals for the maintenance of
mature Treg cell pool size and lineage identity is less well under-
stood. A reporter mouse for TCR signal strength reveals that
Treg cells continuously receive stronger TCR signals than con-
ventional T cells not only during thymic development, but also
in the periphery (Moran et al., 2011). However, mice expressing
major histocompatibility complex class II (MHCII) glycoproteins
only on cortical thymic epithelial cells show normal proportions
of CD4+ CD25+ T cells in peripheral lymph nodes (Bensinger
et al., 2001), suggesting that homeostasis of mature Treg cells
is to a large degree MHCII independent. Furthermore, graded
interference in TCR signaling strength by ZAP mutations leads
to a reduced number of Treg cells in the thymus, but not in the
spleen (Siggs et al., 2007). In contrast, ablation of MHCII expres-
sion specifically on CD11chi dendritic cells significantly reduces
proportions and the absolute number of Treg cells in lymph
nodes and spleen (Darrasse-Je`ze et al., 2009).
To directly address the importance of tonic TCR signaling for
peripheral Treg cell homeostasis and lineage identity, we moni-
tored the consequences of induced TCR ablation on mature
Treg cells. Our results show that although TCR-deficient Treg
cells maintain Foxp3 expression and their lineage-specific hypo-
methylation pattern, continuous TCR signals are required to
maintain their activated phenotype, homeostasis, and their
immunosuppressive properties. Therefore, we propose that
TCR-derived signals are not only critical during thymic develop-
ment, but also for the maintenance and function of peripheral
Treg cells.
RESULTS
Foxp3 Expression Is Independent of Continuous TCR
Signals in Mature Peripheral Treg Cells
In order to study the importance of TCR signaling for Treg cells
in vivo, we ablated the TCRa chain by poly(I:C) injection
of Mx1-cre TcraF/F mice. This leads to downregulation of TCRb-
chain and CD3 surface expression after 5 days and nearly
complete surface absence of both molecules after 10 days
(Polic et al., 2001). Two weeks after poly(I:C) treatment, around
25% of the Foxp3+ Treg cells had lost TCR surface expression
(see Figure S1A available online). To facilitate the identification
of Treg cells, Mx1-cre TcraF/F mice were bred to the Foxp3-I-
eGFP reporter strain (Bettelli et al., 2006), in which GFP expres-
sion reports Foxp3 mRNA amounts (TcraF/F stands for TcraF/F
and TcraF/F Foxp3-I-eGFP throughout the manuscript). We
analyzed Treg cells 6 weeks after induced TCR ablation unless
otherwise indicated, so that they lacked TCR signals for at leastI1 month. Our analyses were conducted mostly with thymus-
derived Treg cells, because we detected only very low numbers
of Nrp1lo peripherally derived pTreg cells in the spleen (Fig-
ure S1B). Importantly, 6 weeks after TCR loss, TCR-deficient
Treg cells still expressed high Foxp3 amounts and were exclu-
sively CD25hi (Figures 1A–1C and S1C and S1D). Analyses of
Mx1-cremT/mG reporter mice (Muzumdar et al., 2007) revealed
equal Cre-mediated recombination efficiencies in various Treg
cell subsets, including CD25lo Treg cells, at this time point (Fig-
ure S1E). This indicates that CD25lo Treg cells were either lost
or upregulated CD25 after TCR ablation. Because CD25hi and
CD25lo Treg cells differ in their gene expression and proliferation
(Fontenot et al., 2005), we compared CD25hi TCR-deficient
to TCR-expressing CD25hi Treg cells unless stated otherwise.
Foxp3 protein levels of TCR– (CD25hi) Treg cells were slightly
reduced (10%) in comparison to TCR+ CD25hi Treg cells, but still
significantly higher than those of TCR+ CD25lo Treg cells (Figures
1A and S1C). GFP amounts reporting Foxp3mRNAwere virtually
identical between TCR+ CD25hi and TCR– Treg cells (Figures 1B
and S1D). This indicates that TCR signals induce posttransla-
tional stabilization of the Foxp3 protein. GFP-expression and
hence Foxp3mRNA amounts remain stable in all TCR– Treg cells
at 4, 8, or 12 days after induced TCR ablation while Foxp3 protein
amounts decrease to their final levels within 8 days (Figures S1F
and S1G).
Together, these experiments demonstrate that continuous
TCR signals are largely dispensable for the maintenance of
Foxp3 expression of mature Treg cells.
The Treg Cell-Specific Epigenetic Pattern Is Not
Affected by TCR Ablation
Besides Foxp3 expression, the establishment of a specific hypo-
methylation pattern (nTreg-Me), especially within the gene loci
of Foxp3, Gitr, Ctla4, and Ikzf4 (Eos), is of critical importance
during thymic Treg cell development (Ohkura et al., 2012).
Long-lasting TCR stimulation of developing thymocytes is
shown to induce nTreg-Me whereas Foxp3 expression is a
consequence of strong TCR activation (Ohkura et al., 2012).
Bisulfite sequencing of purified TCR-deficient and proficient
Treg cells 6 and 15 weeks after poly(I:C)-induced TCR ablation
did not reveal changes in the Treg cell-specific methylation
pattern (Figure 1D). In line with this finding, the protein amounts
of genes that contain hypomethylated regulatory regions
were, albeit reduced, still significantly higher in TCR-deficient
Treg cells than in naive conventional T cells (Figures 1A, 1E,
and 2D). Furthermore, we also did not detect major differences
in the mRNA expression levels of several additional genes con-
taining Treg cell-specific DNA demethylated regions (Morikawa
et al., 2014) (Figure S1H).
These results demonstrate that maintenance of the Treg
cell-specific methylation pattern is completely independent of
continuous TCR signals. Hypomethylation therefore uncouples
the expression of key Treg cell genes from obligate TCR signals
to a large extent.
TCRSignalsContinuously ActivatePeripheral TregCells
The peripheral Treg cell pool contains naive and effector or
tissue-homing subsets (Campbell and Koch, 2011; Fisson
et al., 2003). Naive Treg cells are quiescent and expressmmunity 41, 722–736, November 20, 2014 ª2014 Elsevier Inc. 723
Figure 1. Foxp3 Protein Expression and Treg Cell-Specific Methylation Pattern Remain in Absence of TCR Signals
(A and B) Intracellular Foxp3 expression (A) and Foxp3-I-eGFP expression (B) 6 weeks after poly(I:C) injection. Median fluorescence intensities (MFI)
were normalized to CD25hi Treg cells of TcraF/F animals, then set to 1 for CD4+ conventional T cells (A), or normalized to CD25hi Treg cells of TcraF/F animals
in percentage (B). Numbers below the plot indicate means of the normalized MFIs and were calculated from 10 mice per genotype from 4 independent
experiments (A) and from 16 mice per genotype from 5 independent experiments (B). ***p < 0.001; *p < 0.05; ns, not significant; one-way ANOVA.
(C) Surface CD25 and TCRb expression on Foxp3-I-eGFP+ Treg cells 6 weeks after poly(I:C) injection. Numbers indicate mean percentage ± SD ofR 14mice per
genotype fromR 4 independent experiments.
(legend continued on next page)
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TCR Signals in Mature Regulatory T Cell BiologyCD62L and the chemokine receptor CCR7, enabling them to
enter secondary lymphoid organs (Campbell and Koch, 2011).
In contrast, effector Treg cells are cycling and show increased
expression of CD5, CD38, CD44, Ox40, GITR, CD69, and
ICAM-1 (Campbell and Koch, 2011; Feuerer et al., 2009; Fisson
et al., 2003; Fontenot et al., 2005; Huehn et al., 2004; Stephens
et al., 2007). A direct comparison of the CD25hi to the CD25lo
Treg cell subsets reveals that the CD25lo subset is enriched for
proliferating cells expressing effector markers (Fontenot et al.,
2005). It was proposed that the effector Treg cell subset is
comprised of short-lived cells that were recently activated by
(self-)antigens (Campbell and Koch, 2011; Fisson et al., 2003).
TCR ablation did not reduce the proportions of Treg cells
expressing CCR7 and CD62L, suggesting that TCR-deficient
Treg cells can recirculate efficiently between secondary lym-
phoid organs (Figure S2A). In contrast, we observed that acti-
vation and/or effector markers such as 4-1BB, CD49b, CD69,
PD-1, and KLRG1 were virtually absent on TCR-deficient Treg
cells (Figure 2A).
To further elucidate the impact of TCR signals for Treg cell
identity, we monitored the protein amounts of well-described
Treg cell markers after TCR ablation. Our analysis revealed
that surface amounts of the costimulatory molecules ICOS,
CD28, and Ox40, as well as of CD38, CD44, CD5, ICAM-1, and
TIGIT, were significantly decreased, whereas CD45RB was up-
regulated (Figures 2B and S2B). Fittingly, relative quantification
of intracellular transcription factor protein amounts showed
that Egr2, c-Rel, and c-Maf, which have been linked to TCR acti-
vation, were dramatically downregulated (Figures 2C and 2D).
The expression of several other important transcription factors
connected to Treg cell function (Fu et al., 2012; Rudra et al.,
2012) such as IRF4, Helios, GATA3, KLF4, T-bet, and Aiolos,
but not Runx1 and Bcl-6, was significantly reduced in the TCR-
deficient cells, although not to the amounts found in naive
CD4+ T cells (Figures 2C, 2D, and S2C). A comprehensive
overview of surface-marker proteins and transcription factors
analyzed by flow cytometry is shown in Figure 2D.
We then assessed the dynamic changes in protein levels of
selected markers 4, 8, and 12 days after TCR ablation. At day
4 TCR downregulation was similar in all tested Treg cell subsets,
including CD25lo, CD69hi, and CD103+ (Figure S2D), confirming
equal TCR ablation efficiencies between different Treg cell sub-
sets. The TCR-deficient effector Treg cell subsets slowly shrank
in size, with the exception of the CD103+ subset (Figures S2E
and S2F). Over time, TCR-deficient Treg cells gradually lost
TCR-dependent surface marker and transcription factor expres-
sion (Figures 2E and S2G–S2I). This occurred on CD25hi and as
long as they persisted also on CD25lo subsets (Figure S2H) and
on individual effector subset defined by high-marker protein
expression (Figure S2I). We did not detect increased proportions
of dead or dying Treg cells at any time point after TCR ablation by
propidium iodide and Annexin V staining (Figure S2J). Therefore,
individual Treg cell effector subsets are slowly disappearing in(D) CpGmethylation status of splenic CD25hi TCR+ and TCR– Foxp3+ Treg cells, 6
in vitro-induced Treg.
(E) Intracellular (CTLA4, Eos) or extracellular (GITR) expression of the indicated sp
poly(I:C) injection. Numbers in representative histograms indicate means of the M
were calculated fromR 5 mice per genotype fromR 2 independent experiment
Iresponse to TCR ablation, and this goes hand-in-hand with
loss of typical gene expression.
We conclude that de novo differentiation and maintenance of
effector Treg cell subset phenotypes cannot occur in absence of
TCR signals. Furthermore, our analysis of effector-type and
‘‘naive’’ CD25hi TCR-deficient Treg cells showed a substantial
loss of lineage-defining protein expression. However, although
in absence of TCR signals the protein amounts of some activa-
tion markers and transcription factors were reduced to amounts
found on naive conventional CD4+ T cells, the majority of pro-
teins were present at amounts in between conventional CD4+
T and Treg cells.
TCR-Dependent Gene Expression in Treg Cells
Is Dominated by TCR-Induced Transcription
Factors and IRF4
To examine the consequences of the loss of TCR signals glob-
ally, we analyzed gene-expression changes through Affymetrix
microarrays. In total, loss of the TCR affected the expression
of 327 genes at least 2-fold and of 65 genes at least 3-fold in
CD25hi Treg cells. The majority of these genes were downregu-
lated (71% of the 2-fold regulated genes and 68% of the 3-fold
regulated genes); this included genes encoding for cell surface
molecules such as 4-1BB (encoded by Tnfrsf9), CD38, ICOS,
and PD-1 (encoded by Pdcd1) as already observed by flow cy-
tometry (Figures 2A–2D and Table S1).
TCR ablation affected various gene subsets (defined in Table
S2): Of Treg cell signature genes, 15 (4%) were significantly
reduced to less than 1/3 and 135 (30%) were reduced to less
than 2/3 of their expression in TCR
+ Treg cells, while only a minor
fraction was upregulated (Figure 3A). This indicates that while a
proportion of the characteristic Treg cell gene expression relies
at least partially on TCR-derived signals, overall TCR-deficient
Treg cells maintain their cellular identity.
In agreement with the persistent Foxp3 protein amounts
in TCR-deficient Treg cells, Foxp3-regulated genes were not
strongly affected. Nevertheless, over 30% of the Foxp3-acti-
vated genes in TCR-deficient Treg cells were reduced to less
than 2/3 of their expression in TCR
+ Treg cells (Figure 3B),
defining a candidate set of Foxp3-activated genes that require
TCR signals for full expression. Consistent with the dramatic
loss of Egr2 expression upon TCR ablation, we detected a signif-
icant reduction in Egr2-dependent gene expression (Figure 3C).
A set of general NF-kB target genes was equally up- and down-
regulated (Figure S3A). However, genes whose expression was
reduced in c-Rel-deficient activated T cells weremostly downre-
gulated upon TCR ablation (Figure 3D), underscoring the unique
role of c-Rel among the NF-kB transcription factors in Treg cells.
GATA3- or Runx1-controlled gene expression remained stable
in TCR-deficient Treg cells, as none of them were significantly
regulated more than 2-fold (data not shown). An analysis of
putative NFAT target genes revealed that 30% depend to
some extent on TCR signals in Treg cells (Figure 3E). Amongweeks or 15weeks after poly(I:C) injection. tTreg = thymus-derived Treg; iTreg =
lenic T cell subsets (Treg = Foxp3+), all fromMx1-cre TcraF/F mice 6 weeks after
FIs, normalized to Foxp3– CD4+ CD44lo naive T cells of TcraF/F mice. Means
s. See also Figure S1.
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Figure 2. TCR-Deficient Regulatory T Cells Lose Their Activated Phenotype
(A) Extracellular expression of the depicted markers on splenic Foxp3-I-eGFP+ CD25hi Treg cells, 6 weeks after poly(I:C) injection. Numbers in representative
plots indicate mean percentage ± SD of 6–13 mice per genotype fromR 2 independent experiments.
(B and C) Extracellular (B) or intracellular (C) expression of the depicted markers of the indicated splenic T cell subsets (Treg = Foxp3+), all fromMx1-cre TcraF/F
mice 6 weeks after poly(I:C) injection. Numbers in representative histograms indicate means of the MFIs, normalized to Foxp3– CD4+ CD44lo naive T cells
of TcraF/F mice. For TIGIT, percentage of positive cells are shown. Means were calculated from R 5 mice per genotype from R 2 independent experiments.
***p < 0.001; **p < 0.01; *p < 0.05; one-way ANOVA.
(D) Flow cytometric protein level analysis of extra- and intracellular markers of splenic T cell subsets (Treg = Foxp3+) 6 weeks after poly(I:C) injection. MFIs ofR 3
mice per analyzed protein were normalized to the expression on or in conventional CD4+ T cells to account for interexperimental variations. Data are shown as
(legend continued on next page)
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Figure 3. Treg Cell mRNA Expression Is Severely Changed upon TCR Ablation
(A–F) The mRNA expression of splenic Foxp3-I-eGFP+ TCR+ CD25hi Treg cells from 4 TcraF/F control samples (WT) and Foxp3-I-eGFP+ TCR– CD25hi Treg cells
from 5Mx1-cre TcraF/F samples (KO), 6 weeks after poly(I:C) injection, was compared by Affymetrix microarray. Each sample contained pooled Treg cells from
3-5 mice. Normalized enrichment scores (NES) were calculated at the indicated false discovery rate (FDR) at the GSEA server of the Broad Institute. Changes in
the expression of (A) Treg cell signature genes and (B) direct Foxp3 target genes that are either repressed (top; less than ½ of expression in TCR+ Treg cells:
Tbc1d4) or activated (bottom; less than½ of expression in TCR+ Treg cells: Icos) upon Foxp3 promoter occupancy. Changes in putative target gene expression of
(C) Egr2, (D) REL (c-Rel), (E) NFAT transcription factors, and (F) IRF4 are shown. Pie charts show the number of detected genes within the respective category
(white, not regulated; red,R 1.5-fold upregulated; blue, 2/3 of the expression in TCR
+ Treg cells) in KO relative toWT Treg cells. Heatmaps depict knockout (KO) to
WT fold-change values (Log2-transformed; A,R 3-fold; B–F,R 2-fold) of significantly regulated genes (p < 0.05; t test). See also Figure S3 and Tables S1 and S2.
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were Egr2, Egr3, and IRF4 (Figures 3D, 3E, and S3B), suggesting
a TCR-dependent transcription-factor network. Although IRF4
protein amounts were only reduced by around 20%, TCR abla-
tion had the largest effect on IRF4-controlled gene expression:
57% of the 47 IRF4 target genes were downregulated to less
than 2/3 of their expression in TCR+ Treg cells, 16 (34%) of whichheatmap (Perseus software). Blue letters, significantly (p < 0.05) reduced on or i
control, as well as Mx1-cre TcraF/F mice. Red letters, significantly increased (p <
(E) Decay of the indicated proteins after TCR ablation. Shown are MFIs of TCR
individual mice and means. See also Figure S2.
Istatistically significantly to less than ½ (Figure 3F). Gene-set
enrichment analysis (GSEA) confirmed significant (FDR% 0.05)
loss of Treg signature genes and Foxp3 activated, Egr2, c-Rel,
NFAT, and IRF4 target genes in TCR-deficient Treg cells (Figure 3
and Table S2). Unbiased analysis of the gene-expression data
from TCR-deficient and control Treg cells against publicly avail-
able gene sets suggested loss of Egr3 and Egr2 target genes,n TCR– Treg cells in comparison to TCR+ CD25hi Treg cells from both TcraF/F
0.05); analyzed by one-way ANOVA.
-deficient relative to MFI of TCR+ Foxp3+ Treg cells. Depicted are values for
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Figure 4. Regulatory T Cell Homeostasis Is Impaired upon TCR Ablation
(A) Expression of CD69 and Foxp3 plotted against TCRb on total thymocytes, 6 weeks after poly(I:C) injection. Plots are representative of five independent
experiments.
(B) Number of splenic Foxp3+ Treg cells from in total 24 control (CTR) TcraF/F mice, as well as number of TCR+ and TCR– Treg cells from in total 23Mx1-cre TcraF/F
mice from 14 independent experiments, at the indicated time after poly(I:C) injection. t50% decay = time it takes until the population decayed to half of its size.
(C) Intracellular expression of Ki-67 in splenic Foxp3+ Treg cells, 6 weeks after poly(I:C) injection. Numbers in representative plots indicate mean percentage ± SD
of 4 mice per genotype and are representative for 3 independent experiments.
(D) BrdU was administered for 4 weeks via the drinking water, starting 2 weeks after poly(I:C) injection. Directly afterward, BrdU incorporation in CD25lo and
CD25hi Foxp3+ Treg cells wasmeasured by flow cytometry. Numbers in representative plots indicate mean percentage ± SD of 2–4 mice per genotype. Bar chart
depicts means + SD of one experiment with 2 TcraF/F, as well as 4 Mx1-cre TcraF/F mice. ****p < 0.00001; one-way ANOVA.
(legend continued on next page)
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sion of conventional T cells (Figure S3C).
The overwhelming majority of differentially expressed mRNAs
were downregulated in TCR-deficient Treg cells, indicating that a
large part of the Treg cell-specific gene-expression pattern de-
pends on autoreactive TCR signals. This TCR-dependent gene
expression appears to depend on Egr2, Egr3, c-Rel, and most
prominently, IRF4. However, TCR-deficient Treg cells globally
maintain their transcriptional identity.
The Peripheral Homeostasis of Treg Cells Requires
TCR Signals
Having established that TCR signals are indispensable for the
differentiation and maintenance of effector Treg cells and critical
for the expression of many Treg lineage-defining genes, we
wanted to assess the role of TCR signals for ‘‘naive’’ CD25hi
Treg cell maintenance. Upon poly(I:C) treatment, T cell develop-
ment is blocked inMx1-cre TcraF/F mice, due to complete TCRa
inactivation in lymphoid progenitors (Figure 4A). Therefore, we
employed these mice to study the homeostasis of peripheral
Treg cells in the absence of cellular efflux from the thymus.
The population of TCR– Treg cells decayed (Figure 4B), similar
to TCR-deficient naive CD4+ cells, but in stark contrast to
CD4+ CD44hi memory and effector T cells and CD4+ natural killer
T (NKT) cells, which rely on cytokines but not on TCR stimulation
(Polic et al., 2001; Vahl et al., 2013). The total number of periph-
eral Treg cells was not changed significantly 6 weeks and
15 weeks after induced TCR ablation, unlike the number of naive
CD4+ and CD8+ T cells (Figures 4B and S4A). Thus, the periph-
eral Treg cell pool size is kept stable in the absence of thymic
output.
The decrease of peripheral TCR-deficient Treg cells (Figure 4B)
could be a consequence of impaired survival and/or prolifera-
tion. The proliferation marker Ki-67 was not expressed by
TCR-deficient Treg cells (Figure 4C). In order to directly monitor
the proliferation of Treg cells in the absence of TCR signals, mice
containing TCR-deficient and -proficient Treg cells received
BrdU-containing water for 4 weeks. Over 80% of CD25lo Treg
cells, as well as 40%–50% of TCR+ CD25hi Treg cells incorpo-
rated BrdU during this time (Figure 4D). The BrdU-incorporation
of TCR-deficient Treg cells was negligible, demonstrating that
homeostatic Treg cell proliferation absolutely requires tonic
TCR signals (Figure 4D).
Direct ex vivo analyses suggested that loss of the TCR has no
major impact on the survival of Treg cells (Figure S2J). However,
a significantly higher percentage of TCR-deficient Treg cells con-
tained activated caspases (Figure 4E) after 1 hr in cell culture,
indicating that in vitro, TCR-deficient Treg cells have an
increased tendency to undergo apoptosis.
Cytokines, most importantly IL-2 and IL-7, influence the ho-
meostasis of Treg cells (Setoguchi et al., 2005). While all TCR-
deficient Treg cells expressed high amounts of CD25 (Figure 1C),
expression of CD122 (IL-2R and IL-15R b chain), CD127 (IL-7Ra(E) Splenic Foxp3+ Treg cells were stained in vitro for 1 hr for the presence of activ
TcraF/F mice. Scatterplot shows the percentage of active caspase+ Foxp3+ Treg c
(F) Comparison of STAT5 and STAT3 phosphorylation upon stimulation with IL-2
representative histograms indicate means of the MFIs, normalized to unstimulated
independent experiments (p-STAT5) or from 3 mice (p-STAT3). See also Figure S
Ichain), and the IL-15Ra chain were not significantly altered upon
TCR ablation (Figures 2D and S4B). Importantly, TCR-deficient
Treg cells were competent in cytokine signaling as evidenced
by robust phosphorylation of STAT5 and STAT3 transcription
factors in response to IL-2 and IL-6 stimulation (Figure 4F). In
addition, the homeostatic defects of TCR-deficient Treg cells ap-
peared unrelated to endoplasmic reticulum (ER) stress caused
by an unpaired TCRb chain because we did not detect major
alterations in the expression of genes implicated in the endo-
plasmic reticulum associated degradation (ERAD) and in the
unfolded protein response pathways (Table S2).
Together, these results demonstrate that the absence of TCR
signals effectively abrogates Treg cell homeostasis, due to
essentially abolished proliferation.
Elevated mTOR Signaling in Treg Cells Is TCR Mediated
Signals derived from antigen recognition, costimulation, cyto-
kines, growth hormones, and nutrients converge on the mecha-
nistic target of rapamycin (mTOR) pathway. Signaling through its
two multiprotein complexes, mTORC1 and mTORC2, and the
upstream kinase AKT regulates cellular growth, protein transla-
tion, and survival in many cell types, including T cells (Chi,
2012). Importantly, Treg cells contain and depend on enhanced
mTORC1 signaling for their homeostasis and function (Zeng
et al., 2013).
We detected lower phosphorylation of mTOR and its targets
ribosomal protein S6, kinase p70 S6, the translational inhibitor
4E-BP1, and reduced expression of the mTORC1 target CD71
in TCR– Treg cells (Figures 5A, 5B, and S5A–S5C). We also de-
tected a trend toward downregulation of mTORC1 target genes
controlling the cholesterol biosynthesis pathway (Figures 5C and
S5D), which has a central role in Treg cells (Zeng et al., 2013). In
contrast, we did not observe differences in mTORC1-controlled
mitochondrial parameters including their reactive oxygen pro-
duction, membrane potential, and mass (Figure S5E) (Zeng
et al., 2013).
mTORC2 plays an important role in the inhibition of apoptosis
by directly phosphorylating the kinase AKT at serine 473,
enabling it to phosphorylate and thereby inhibit constitutively
active FoxO transcription factors. TCR-deficient Treg cells con-
tained strongly reduced AKT-S473 phosphorylation (Figure 5D)
and correspondingly reduced FoxO1 phosphorylation at the
AKT target site serine 256, but not protein amounts (Figures 5E
and S5F). The proapoptotic BH3-only protein Bim, a FoxO target
in T cells (Hedrick et al., 2012), was significantly increased upon
TCR ablation (Figures 2B and 5F). Moreover, we observed
decreased amounts of the antiapoptotic protein Bcl-xL in TCR-
deficient Treg cells. On the other hand, the amounts of the anti-
apoptotic protein Bcl-2 were significantly elevated, possibly due
to mutual posttranslational control with Bim (Jorgensen et al.,
2007) (Figures 2B and 5F). Finally, inhibitory phosphorylation of
the proapoptotic Bcl-2 family member Bad, an AKT target (del
Peso et al., 1997), was reduced (Figure 5F). However, globallye caspases. Numbers indicate mean percentage ± SD of 2 TcraF/F or 4Mx1-cre
ells from 2 control TcraF/F or from 4Mx1-cre TcraF/F mice. Bars indicate means.
or IL-6 of the indicated T cell subsets from Mx1-cre TcraF/F mice. Numbers in
Foxp3– CD4+ CD25lo TCR+ T cells. Means were calculated from 6mice from 2
4.
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Figure 5. mTOR Signaling Pathways Are Attenuated in TCR-Deficient Treg Cells
(A, B, D, E, and F) Comparison of phosphorylation or expression of the respective proteins in the indicated splenic T cell subsets (Treg = Foxp3+) 6 weeks after
poly(I:C) injection. Numbers in representative histograms indicate means of the MFIs, normalized to Foxp3– CD4+ CD44lo T cells of TcraF/F mice. Means were
calculated fromR 5 mice per genotype fromR 2 independent experiments. Bars indicate medians. ***p < 0.001; **p < 0.01; one-way ANOVA.
(C) Differences in mRNA expression amounts of the indicated enzymes of the cholesterol biosynthesis pathway normalized to Ywhaz relative to Foxp3– CD4+
conventional T cells (dotted line). Bars indicate means + SD from 3 samples (one mouse per sample for Foxp3– CD4+ T cells and TCR+ CD25hi Foxp3+ Treg cells
and 3 mice pooled per sample for TCR– CD25hi Foxp3+ Treg cells). See also Figure S5.
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sion in TCR– Treg cells (Figure S5G). Therefore, it is also possible
that the observed Bim/Bcl-2 balance is caused by absent
repression of Bcl-2 through complexes containing c-Maf and
c-Myb (Peng et al., 2007), as both are strongly reduced after
TCR ablation (Figures 2C and S3A).
Our results provide correlative evidence that in the absence
of continuous TCR stimulation, signaling through the mTORC1
and mTORC2 pathways is attenuated in Treg cells. Although
we detected only minor effects in downstream gene expression,
these pathways still might be important to keep target genes
in a poised state for rapid expression upon strong Treg cell
stimulation.
TCR-Deficient Treg Cells Lose Most of Their
Suppressive Protein Arsenal and Their Ability
to Suppress T Cell Responses In Vivo
Various mechanisms are implicated in the suppressive ability
of Treg cells (Josefowicz et al., 2012; Sakaguchi et al., 2008;730 Immunity 41, 722–736, November 20, 2014 ª2014 Elsevier Inc.Shevach, 2009). Among them are the consumption of the
cytokine IL-2, the release of suppressive cytokines (IL-10, IL-
35 [composed of p35 and Ebi3] and TGF-b) or toxic molecules
(perforin, granzymes), and the modulation of the costimulatory
abilities of antigen-presenting cells.
Gene-expression analysis of 10 1.5-fold or more regulated
putative suppressor genes revealed that 8 were downregulated
and 2 (Perforin and CD274) were upregulated in TCR-deficient
Treg cells (Figures 6A and S6A). Verification of these and analysis
of further candidates by flow cytometry and/or real-time PCR
(Figures 6B and 6C) revealed that of the 20 putative suppressor
genes tested, 59% (13) were significantly downregulated upon
TCR ablation (Figures 6D and S6A): Nt5e (CD73), Ctla4, Ebi3,
Fgl2, Tnfrsf18 (GITR), Il10, Il10r, Lag3, Tgfb1 (latency associated
peptide, LAP), Itgal (LFA-1), Nrp1, Pdcd1lg2 (PD-L2), and Tigit.
In line with reduced Il10 mRNA expression, a significantly
smaller percentage of TCR– Treg cells produced IL-10 after
PMA and Ionomycin activation in vitro in comparison to their
TCR+ counterparts (Figures 6E and S6B). Importantly,
Figure 6. Regulatory T Cells Show Reduced Expression of Several Important Suppressive Molecules
(A) Heatmap showing mRNA expression of the indicated 1.5-fold regulated suppressive markers of TCR+ versus TCR– Foxp3+ Treg cells, 6 weeks after poly(I:C)
injection, analyzed by Affymetrix microarray.
(B) Extracellular expression of the depicted markers of the indicated splenic T cell subsets (Treg = Foxp3+), all fromMx1-cre TcraF/F mice, 6 weeks after poly(I:C)
injection. Numbers in representative histograms indicate means of the median fluorescence intensities (MFIs), normalized to Foxp3– CD4+ CD44lo naive T cells of
TcraF/F mice. Means were calculated fromR 5 mice per genotype fromR 2 independent experiments.
(C) Differences in mRNA expression amounts of the indicated suppressive markers normalized to Ywhaz relative to Foxp3– CD4+ T cells (dotted line). Bars
indicate means + SD from 3 samples (one mouse per replicate for Foxp3– CD4+ T cells and CD25hi Foxp3+ TCR Treg cells and 3 mice pooled per replicate for
TCR– CD25hi Foxp3+ Treg cells). **p < 0.01; *p < 0.05; t test.
(D) Regulation of 20 putative suppressive molecules in KO relative to WT Treg cells on the mRNA and/or protein amount (white, not regulated; red, upregulated,
blue, downregulated).
(legend continued on next page)
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TCR Signals in Mature Regulatory T Cell BiologyTCR-deficient Treg cells kept their anergic phenotype in respect
to IL-2 (and interferon-g [IFN-g]) production upon activation (Fig-
ures 6E and S6B). After TCR ablation the proportion of TCR– Treg
cells in the gut lamina propria decreased progressively (Fig-
ure 6F). In the ileum, a significantly smaller proportion of TCR–
Treg cells produced IL-10 from day 8 onward. Conversely, in
the colon, TCR– Treg cells largely maintained their ability to
secrete IL-10 (Figures 6F and S6C). This indicates that the cyto-
kine and/or costimulation milieu in the colon can at least partially
substitute antigenic signals with regards to IL-10 production, but
not to cellular homeostasis. We therefore conclude that, overall,
the expression of suppressive genes by Treg cells largely de-
pends on constant TCR signals, even though specific niches
might maintain suppressive functions in absence of antigenic
triggers.
To test the consequences of Treg cell TCR ablation in an in vivo
setting, we employed CD4-CreERT2 animals (Sledzinska et al.,
2013) because of the higher recombination efficiencies in mature
T cells compared to Mx1-cre mice. Application of 3 or 5 mg
tamoxifen for 5 consecutive days leads to loss of the TCR on
around 70% of peripheral Treg cells (Figure S7A). We reconsti-
tuted T cell-deficient mice with naive T cells together with Treg
cells isolated from either TcraF/F control or CD4-CreERT2 TcraF/F
animals (Figure S7B). In the context of T cell deficiency, these
cells rigorously expand. Three weeks after adoptive transfer,
TCR ablation was induced through tamoxifen treatment (Fig-
ure 7A). Three days after cessation of tamoxifen feeding, we
confirmed TCR ablation in 67% and 55% of CD4-CreERT2
TcraF/F Treg cells present in the spleen and mesenteric lymph
nodes, respectively (Figure S7C). The tamoxifen treatment
induced a transient weight loss in all cohorts. However, while
the control animals quickly recovered after cessation of tamox-
ifen feeding, we observed significantly reduced weight gain in
animals in which we ablated the TCR on Treg cells (Figure 7B).
Two of nine experimental animals developed diarrhea and
signs of colitis with severe cellular infiltrations and associated
inflammation (Figure S7D; data not shown). Furthermore, we
noticed increased spleen and mesenteric lymph node weights,
indicating ongoing inflammation, 24 days after TCR ablation
on Treg cells (Figure 7C). This was partially due to infiltration of
eosinophils, monocytes, and/or macrophages, as well as neu-
trophils in both organs (Figures 7D and S7E). At this time point,
total Treg cell counts, of which 20% were TCR-deficient, were
slightly increased in Treg cell TCR ablated animals, indicating a
strong compensatory proliferation of TCR+ Treg cells. The num-
ber of pTreg cells was not increased (Figure S7F). However, the
initial yet transient presence of over 50% of TCR-deficient Treg
cells was sufficient to disrupt normal immune homeostasis.
Importantly, we also observed strongly increased numbers of
CD4+ T cells (Figure 7E), which showed an activated phenotype
as indicated by increased CD69 expression (Figure 7F). Among
the significantly expanded CD4+ T cell subsets were T helper
17 (Th17) cells (Figure 7G) that are commonly connected to(E) Percentages of splenic Foxp3+ Treg cells expressing IL-2, IL-10, or IFN-g upon
mice and activated 6 weeks after poly(I:C) injection. Bars indicate medians. ***p
(F) Percentages of TCR– Treg cells of total Treg cells isolated from the gut lamin
injection (right y axis). After stimulation with PMA and Ionomycin IL-10 production
Bars indicate means ± SD that were calculated fromR 3 mice per time point. *p
732 Immunity 41, 722–736, November 20, 2014 ª2014 Elsevier Inc.autoimmunity and inflammatory disease settings and are under
strict control of regulatory T cells (Josefowicz et al., 2012).
Reduced production of IL-10 also could contribute to disease
development. In a similar experiment in Rag2–/– mice (Figures
S7G–S7J), we did not observe differences in weight (data not
shown), likely due to lower TCRablation efficiencies (FigureS7H).
However, TCR ablation exacerbated intestinal pathology (Fig-
ure S7I) and significantly increased numbers of splenocytes,
including CD4+ T cells (Figure S7J).
In order to test conditional Treg cell TCR ablation in an auto-
immune disease setting with an unmanipulated effector T cell
compartment, we used an experimental autoimmune encepha-
lomyelitis (EAE) model (Figure 7H). Here, we transiently erased
the Foxp3+ Treg cell compartment by diphtheria toxin injections
in DEREG mice and replenished the peripheral Treg cell niche
with in vitro expanded control Treg cells (TcraF/F) or Treg cells
with a tamoxifen-ablatable TCR (CD4-CreERT2 TcraF/F) (Fig-
ure S7K). Upon immunization with MOG35–55 in complete
Freund’s adjuvant (CFA), we found that mice that received
Treg cells whose TCRwas ablated in vivo 6 days after immuniza-
tion developed more severe EAE and behaved like mice who did
not receive Treg cells after depletion of endogenous Treg cells
(Figure 7I). The expansion of endogenous Treg cells, which is
typical of the DEREG model, most likely masks the effects of
TCR ablation at later time points after EAE induction. We ob-
tained similar results when a higher number of Treg cells were
transferred (Figures 7J and S7L and S7M).
Altogether, these results strongly support the notion that in
the absence of continuous TCR signaling, Treg cells lose their
ability to control normal immune homeostasis and to suppress
autoimmune reactions.
DISCUSSION
Treg cells can be broadly separated into two different subsets
in vivo. Naive, slowly cycling Treg cells and the effector subset,
which is composed of highly proliferative cells characterized
by a generally more activated state, likely due to recent auto-
antigen recognition. In line with this hypothesis, six weeks after
TCR ablation we failed to detect TCR-deficient Treg cells
expressing any of the characteristic activated or effector T cell
markers, even though initial TCR ablation in these subsets was
as efficient as in naive Treg cells. Our data thus clearly demon-
strate that effector Treg cells cannot be generated or maintained
in absence of TCR signals.
We propose that TCR-independent hypomethylation and
Foxp3 expression in conjunction with other unaffected transcrip-
tion factors largely ensure continued identity of TCR– Treg cells.
Nevertheless, a large proportion of the Treg cell-defining gene
expression, including Foxp3-regulated genes, depended on
TCR signals to varying degrees. This might be explained by a dif-
ferential dependence on strictly TCR controlled transcription
factors such as Egr2, c-Maf, and c-Rel, and possibly also factorsin vitro activation with PMA and Ionomycin for 5 hr. Cells were extracted from
< 0.001; ns, not significant; one-way ANOVA.
a propria of Mx1-cre TcraF/F mice at the indicated time points after poly(I:C)
was assessed in TCR– CD25hi and TCR+ CD25hi Foxp3+ Treg cells (left y axis).
< 0.05; ns, not significant; t test. See also Figure S6.
Figure 7. In Vivo TCR Ablation of Treg Cells Leads to Inflammation
(A–G) T cell-deficient Tcra–/– mice were reconstituted with Foxp3-I-eGFP– naive T cells together with CD4+ CD25hi Treg cells from either TcraF/F control or from
CD4-CreERT2 TcraF/F mice. After 3 weeks of engraftment, TCR ablation was induced through tamoxifen feeding. Twenty-four days later, animals were sacrificed
and analyzed.
(B) Body weight of the animals, normalized to the respective weight on the first day of tamoxifen treatment. Shown are means ± SEM; SEM are shown for visual
clarity; *p < 0.05; t test.
(C) Weight of the indicated organs. Bars indicate medians. *p < 0.05; ns, not significant; one-way ANOVA.
(D, E, andG) Total cell numbers of (D) eosinophils (CD11c– CD11b+ SiglecF+ SSC-Ahi); (E) CD4+ T cells (TCRb+ CD5+); (G) Th17 T cells (Ror-gt+ CD4+ TCRb+ CD5+).
Bars indicate medians. **p < 0.01; *p < 0.05; ns, not significant; one-way ANOVA.
(legend continued on next page)
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TCR Signals in Mature Regulatory T Cell Biologyof the NFAT family. Surprisingly, target gene analysis pointed to
IRF4 as a critical mediator of TCR-induced gene expression,
although its protein amounts were only moderately affected
by TCR loss. This indicated a critical role for TCR signals in
controlling IRF4 activity in Treg cells, directly or through its tran-
scriptional coregulators. We also found that loss of TCR signals
correlated with a reduction of mTORC1 and mTORC2 activity in
Treg cells to an amount comparable to naive CD4+ T cells.
With respect to homeostatic maintenance, TCR– Treg cells
behaved identically to TCR– naive CD4+ T cells. In striking
contrast to memory T and NKT cells (Polic et al., 2001; Vahl
et al., 2013), TCR signals were indispensable for the proliferation
of Treg cells under steady-state conditions in vivo. In the
absence of thymic output, this nondividing pool of TCR-deficient
Treg cells was reduced to half its size in 46 days, corresponding
to a Treg cell loss of around 1.5% per day. Because directly
ex vivo isolated TCR-deficient Treg cells were as viable as
their TCR-proficient counterparts, this indicates that the decay
of TCR-deficient Treg cells in vivo was not due to enhanced
cell death but due to essentially abolished proliferation. The
protein amounts of and balance between pro- (Bim) and anti-
apoptotic (Bcl-2) proteins in TCR– Treg cells resembled those
found in naive CD4+ T cells and were markedly different from
TCR+ Treg cells. Potential mechanisms for this phenomenon
are attenuated AKT and mTORC2 signaling and/or other tran-
scriptional regulation. Upon egress from the thymus, regulation
of peripheral Treg cell homeostasis has been mainly attributed
to cytokine signaling (Setoguchi et al., 2005). Conversely, we
found that the homeostasis of TCR-deficient Treg cells was
strongly impaired even though they expressed normal amounts
of cytokine receptors for IL-2, IL-7, and IL-15 and signaled nor-
mally in response to IL-2 or IL-6 stimulation. Instead, our results
suggest that constant TCR triggering constitutes an obligate
prerequisite. It should be mentioned that in our experimental
system, Cre-mediated TCR ablation in Treg cells is not com-
plete, and therefore TCR-deficient Treg cells are competing
with TCR-expressing cells. It is possible that the homeostatic
defects of TCR-deficient Treg cells are confounded by this
competition.
Loss of individual suppressive proteins in Treg cells does not
match the dramatic phenotype of Foxp3-deficiency. Thus,
depending on the type of immune response and the location
in the body, several different suppression mechanisms are
important. Still, it is not well understood how Treg cell TCR
engagement is involved in suppression of target cells. At least
in vitro, directly ex vivo isolated Treg cells are able to suppress
without previous activation (Szymczak-Workman et al., 2009).
It has been speculated that autoantigen recognition is key to
maintain polyclonal Treg cells in an activated state, allowing
them to control various different immune responses indepen-
dently of TCR specificity (Shevach, 2009). Our data imply that(F) CD69 expression on CD4+ T cells. Scatterplots showmeans of the MFIs, norma
way ANOVA.
(H) Scheme of EAE experiment: DEREGmice were depleted of endogenous Treg
with control (TcraF/F/ DEREG) or TCR ablatable CD4+ CD25hi Treg cells (CD4-
(I and J) EAE experiment with 33 105 (I) or 23 106 (J) adoptively transferred TcraF/
unreconstituted. Mean clinical disease scores ± SEMof the indicated groups (n = 6
U test. Body weight, shown on the right, was normalized to the first measured w
734 Immunity 41, 722–736, November 20, 2014 ª2014 Elsevier Inc.TCR signals are absolutely required for the differentiation and
maintenance of effector Treg subsets, which is critical for
effective control of overshooting autoimmune or inflammatory
responses in various disease contexts. Furthermore, in naive
Treg cells, constant TCR triggers ensure high expression of
most suppressive proteins. Treg cell TCR ablation in two in vivo
models resulted in increased clinical effects, despite the fact
that Treg cell TCR ablation remained incomplete at around
50%–70%. One possibility is that TCR– Treg cells are unable to
suppress but still occupy homeostatic niches and thereby
impede the action of TCR+ Treg cells.
In summary, our study demonstrates that Treg cells con-
tinuously receive biologically relevant signals through their auto-
reactive TCR and that these signals are essential for Treg cell
homeostasis, signature gene expression, and especially for their
suppressive functions. By ablating the TCR, we abolishedMHCII
recognition and (auto-)antigenic stimulation, and it is likely that
both deficiencies contribute to varying degrees to the effects
we observe. Future studies should aim at dissecting these indi-
vidual contributions. In essence, our study solidifies the view of
the Treg cell population as a constantly TCR-activated T cell
subset whose activation is channeled into suppression through
the actions of Foxp3.
EXPERIMENTAL PROCEDURES
Genetically Modified Mice
Mx1-cre (Ku¨hn et al., 1995), TcraF and Tcra (Tcratm1Cgn; Polic et al., 2001),
Foxp3-I-eGFP (Bettelli et al., 2006), CD4-CreERT2 (Sledzinska et al., 2013),
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J (mT/mG; Muzumdar et al., 2007),
and CD45.1-congenic DEREG (Lahl et al., 2007) mice were all kept on a
C57BL/6 genetic background. Six- to eight-week-old Mx1-cre TcraF/F or
TcraF/F mice were given a single dose (400 mg) of poly(I:C) (Amersham). All
mice were analyzed 6 weeks later, unless otherwise indicated. Mice were
housed in specific pathogen-free animal facilities of the MPIB and the Techni-
sche Universita¨t Mu¨nchen. All animal procedures were approved by the
Regierung of Oberbayern.
Flow Cytometry
Single-cell suspensions were prepared and stained with the antibodies listed
under Supplemental Experimental Procedures.
BrdU Incorporation
Mice were fed with 0.5 mg/mL BrdU (Sigma) in the drinking water for 4 con-
secutive weeks, and BrdU incorporation was measured with the BrdU Flow
Kit (BD).
Cell Sorting and Gene-Expression Analysis
TCR+ (Foxp3+ CD4+ CD25hi cells from TcraF/F Foxp3-I-eGFP mice) and TCR–
(Foxp3+ TCR– CD4+ CD25hi cells from Mx1-cre TcraF/F Foxp3-I-eGFP mice)
Treg cells were sorted 6 weeks after poly(I:C) injection with a FACSAria
(BD). Cells from three to five mice were pooled for sorting one replicate,
and four replicates for the controls as well as five replicates for the Mx1-
cre TcraF/F Foxp3-I-eGFP mice were generated. mRNA from 3–5 3 105 cells
was purified with a RNeasy Micro kit (QIAGEN), amplified, labeled, andlized to splenic CD4+ T cells of control mice. *p < 0.05; ns, not significant; one-
cells by diphtheria toxin and then left unreconstituted (DEREG) or reconstituted
CreERT2 TcraF/F/ DEREG) followed by induction of EAE.
F or CD4-CreERT2 TcraF/F CD4+ CD25hi Treg cells or DEREGmice that were left
) are shown on the left. SEM is shown for visual clarity. *p < 0.05;Mann-Whitney
eight of the respective animal; *p < 0.05; t test. See also Figure S7.
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TCR Signals in Mature Regulatory T Cell Biologyhybridized to Affymetrix M430 V2 microarrays (Geo: microarray data,
GSE62532). Array normalization and expression value calculation was
performed using DNA-Chip Analyzer (www.dchip.org). Heatmaps were
generated with GenePattern Software. Gene set enrichment analysis
(GSEA) was performed at http://www.broadinstitute.org/gsea/index.jsp.
RNA from sorted cells was isolated (QIAGEN) and reverse transcribed
(Promega) for qRT-PCR with Universal Probe Library probes and primers
(Roche Diagnostics).
CpG Methylation Analysis by Bisulfite Sequencing
TCR+ and TCR– Treg cells were sorted 6 weeks and 15 weeks after poly(I:C)
injection as for the gene expression analysis. Control tTreg and iTreg cells
were generated, and the CpG methylation status was analyzed, as previously
described (Ohkura et al., 2012).
In Vivo Suppression Assays
T cell-deficient Tcra–/– mice at the age of 6–8 weeks were reconstituted with
1 3 106 naive CD4+ T cells (Foxp3-I-eGFP– CD45RBhi CD25–) together
with 0.25 3 106 Treg cells (CD4+ CD25hi CD45RBint CD38hi) from either
CD4-CreERT2 TcraF/F or littermate control mice. Starting 3 weeks after cell
transfer, mice were fed per os with 5 mg tamoxifen per day (Sigma) for 5
consecutive days, and their weight was monitored. Colon samples were
fixed in 4% paraformaldehyde, embedded in paraffin, sectioned, and stained
with hematoxylin and eosin. For the EAE model, endogenous DEREG CD45.1
Treg cells were depleted by injection of 500 ng diphtheria toxin (Calbiochem)
on days 2 and 1 prior to immunization and substituted by 0.3 3 106 or 2 3
106 Treg cells obtained from either CD4-CreERT2 TcraF/F or littermate con-
trols. EAE was induced by s.c. immunization with 200 mg of MOG35-55
(Auspep) in CFA containing 500 mg M. tuberculosis H37Ra (Difco) plus
intravenous injection of 200 ng pertussis toxin (Sigma) on days 0 and
2 after immunization. Starting on day 5 postimmunization, mice were fed
with tamoxifen (Hexal) in ClinOleic 20% (Baxter) for 5 consecutive days
(0.15 mg/g z3 mg/mouse on day 5 and 0.10 mg/g z2 mg/mouse on the
following days). Disease progress and severity were assessed as published
(Korn et al., 2007).
Statistics
Statistical analysis of the results was performed by one-way ANOVA followed
by Tukey’s test, by Student’s t test as indicated. p values are presented in
figure legends where a statistically significant difference was found. EAE
scores between groups were analyzed as disease burden per individual day
with Mann-Whitney U test.
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